BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20175005)

  • 1. Distress and alexithymia in lung recipients - psychosocial strains and associations with chronic allograft dysfunction.
    Goetzmann L; Irani S; Schwegler K; Stamm M; Bricman R; Buddeberg C; Schmid C; Benden C; Klaghofer R; Boehler A
    Swiss Med Wkly; 2010 Jun; 140(25-26):382-7. PubMed ID: 20175005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled nitric oxide and carbon monoxide in lung transplanted patients.
    Cameli P; Bargagli E; Fossi A; Bennett D; Voltolini L; Refini RM; Gotti G; Rottoli P
    Respir Med; 2015 Sep; 109(9):1224-9. PubMed ID: 26224473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and bronchiolitis obliterans syndrome in patients after lung transplantation.
    Künsebeck HW; Kugler C; Fischer S; Simon AR; Gottlieb J; Welte T; Haverich A; Strueber M
    Prog Transplant; 2007 Jun; 17(2):136-41. PubMed ID: 17624136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled nitric oxide after lung transplantation: impact of the native lung.
    Verleden GM; Dupont LJ; Delcroix M; Van Raemdonck D; Vanhaecke J; Lerut T; Demedts M
    Eur Respir J; 2003 Mar; 21(3):429-32. PubMed ID: 12661996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
    Finlen Copeland CA; Snyder LD; Zaas DW; Turbyfill WJ; Davis WA; Palmer SM
    Am J Respir Crit Care Med; 2010 Sep; 182(6):784-9. PubMed ID: 20508211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in basement membrane thickness in airway walls post-lung transplantation.
    Law L; Zheng L; Orsida B; Levvey B; Oto T; Kotsimbos AT; Snell GI; Williams TJ
    J Heart Lung Transplant; 2005 Oct; 24(10):1571-6. PubMed ID: 16210132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross sectional study of exhaled nitric oxide levels following lung transplantation.
    Fisher AJ; Gabbay E; Small T; Doig S; Dark JH; Corris PA
    Thorax; 1998 Jun; 53(6):454-8. PubMed ID: 9713443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiolitis obliterans syndrome in lung transplant recipients: correlation of computed tomography findings with bronchiolitis obliterans syndrome stage.
    Choi YW; Rossi SE; Palmer SM; DeLong D; Erasmus JJ; McAdams HP
    J Thorac Imaging; 2003 Apr; 18(2):72-9. PubMed ID: 12700480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.
    Verleden GM; Dupont LJ; Van Raemdonck D; Vanhaecke J
    J Heart Lung Transplant; 2003 Aug; 22(8):908-13. PubMed ID: 12909472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
    Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML
    Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients.
    Calhoun R; SivaSai KS; Sundaresan S; Trulock EP; Lynch JP; Patterson GA; Cooper JD; Mohanakumar T
    Transpl Int; 1999; 12(6):439-46. PubMed ID: 10654356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors for the development of bronchiolitis obliterans syndrome.
    Husain AN; Siddiqui MT; Holmes EW; Chandrasekhar AJ; McCabe M; Radvany R; Garrity ER
    Am J Respir Crit Care Med; 1999 Mar; 159(3):829-33. PubMed ID: 10051258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
    Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.